Full name
"APTEKA ELIKSIR" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
"APTEKA ELIKSIR" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. HRUBIESZOWSKA 16, 71-047 SZCZECIN
TAX ID8522376984
Rate company:
"APTEKA ELIKSIR" SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID8522376984
KRS0000110879
Share capital50,000.00 zł
address
UL. HRUBIESZOWSKA 16, 71-047 SZCZECIN
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
8522376984
REGON
812549878
KRS
0000110879
Legal form
limited liability company
Register Address
UL. HRUBIESZOWSKA 16, 71-047 SZCZECIN
Date of registration in KRS
2002-05-09
Date of commencement of economic activity
2002-05-09
Act signature
RDF/628958/24/924
Pkd codes
47.73.Z - Dispensing chemist in specialised stores
21.20.Z - Manufacture of medicines and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopaedic goods in specialised stores
47.75.Z - Retail sale of cosmetic and toilet articles in specialised stores
68.20.Z - Rental and operating of own or leased real estate
73.12.D - Intermediation in the sale of the place on advertising aims in other media
Payer VAT status
Active
Vat list bank account(s)
PL11 1500 1722 1217 2005 1375 0000 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 0,1 | 0,1 | 0,1 | -47,5 |
EBITDA | 0,1 | 0,1 | 0,1 | -43,4 |
Short time liabilities | 0,1 | 0,2 | 0,2 | 12,9 |
Equity capital | 0,2 | 0,3 | 0,2 | -19,7 |
Operating profit (EBIT) | 0,1 | 0,1 | 0,1 | -47,5 |
Assets | 0,3 | 0,4 | 0,4 | -6,9 |
Net profit (loss) | 0 | 0,1 | 0,1 | -47,6 |
Cash | 0 | 0,1 | 0 | -40,9 |
Net income from sale | 2 | 2,4 | 2,5 | 6,5 |
Liabilities and provisions for liabilities | 0,1 | 0,2 | 0,2 | 13,7 |
Working assets | 0,3 | 0,3 | 0,3 | -8,8 |
Depreciation | 0 | 0 | 0 | 757,1 |
% | % | % | p.p. | |
Profitability of capital | 24,3 | 41,4 | 27 | -14,4 |
Equity capital to total assets | 58,6 | 61,8 | 53,3 | -8,5 |
Gross profit margin | 2,6 | 5,1 | 2,5 | -2,6 |
EBITDA Margin | 3,1 | 5,1 | 2,7 | -2,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 27 | 25 | 27 | 2 |
Current financial liquidity indicator | 1.750809669494629 | 2.035081624984741 | 1.6314750909805298 | -0,4 |
Net dept to EBITDA | -0.15740787982940674 | -0.6376442313194275 | -0.6999652981758118 | -0,1 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (1)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
CYTOGEN-POLSKA
ŁÓDŹ
E FARM PL S C
Rąbień
EUR-MED POLSKA
Katowice
Merkury S.A.
Białystok
TBK MEDICAL PARTNER
ŻYWIEC
Interton.pl sp. z o.o.
Kraków